Clinical Trial

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single-dose subcutaneous injection of SHR-3045 in healthy subjects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-23; most recent amendment 2026-06-09.
Status change: Recruiting → Completed 2026-06-09
Status change: Not Yet Recruiting → Recruiting 2025-11-13
Trial Details
NCT Number NCT07200596
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Rheumatoid Arthritis (RA)
Enrollment 16 participants
Start Date 2025-10-08
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-11